← Back to Search

Mediterranean Diet for Obesity in Pregnancy (MedDiet Trial)

N/A
Waitlist Available
Led By Julio Mateus Nino, MD, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks, 16, 24, 30 and 40
Awards & highlights
No Placebo-Only Group

Summary

This trial compares two healthy diets in pregnant women to see which one is most beneficial. Participants randomly receive either ACOG program or MedDiet. Both diets focus on eating plants, with MedDiet emphasizing olive oil and limiting red meat. Participants get free food and assessments.

Who is the study for?
This trial is for overweight or obese pregnant women in their first trimester, with a BMI of 25.0 kg/m2 or higher. They must be at least 18 years old and speak English or Spanish. Women with multiple pregnancies except those reduced to a singleton are not eligible.
What is being tested?
The study compares two diet programs during pregnancy: the routine ACOG-based dietary advice versus the Mediterranean Diet (MedDiet) program, which emphasizes plant-based foods and olive oil as the main fat source. Participants will receive free food and guidance according to their assigned diet plan.
What are the potential side effects?
Since this trial involves healthy eating programs rather than medications, side effects are minimal but may include changes in digestion due to dietary adjustments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks, 16, 24, 30 and 40
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks, 16, 24, 30 and 40 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Diet Adherence Assessment Scores
Secondary study objectives
Cardiometabolic biomarkers - C-reactive protein (CRP) levels
Cardiometabolic biomarkers - glucose level
Cardiometabolic biomarkers - hemoglobin A1C levels
+4 more
Other study objectives
Number of Adverse Pregnancy Outcomes (APO)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mediterranean Diet (MedDiet) ProgramExperimental Treatment1 Intervention
Well-known healthy diet that consists of a large amount of plant-based foods such as fruits, vegetables, beans, and nuts with extra virgin olive oil (EVOO) as the principal source of fat. Dairy, fish, and poultry are consumed in moderation and red meat only eaten occasionally.
Group II: American College of Obstetricians and Gynecologists (ACOG)-based Dietary ProgramActive Control1 Intervention
Routine dietary counseling program

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH
365 Previous Clinical Trials
412,554 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,394 Previous Clinical Trials
2,459,976 Total Patients Enrolled
1 Trials studying Gestational Weight Gain
12 Patients Enrolled for Gestational Weight Gain
Julio Mateus Nino, MD, PhDPrincipal InvestigatorWake Forest University Health Sciences

Media Library

ACOG-based Dietary Program Clinical Trial Eligibility Overview. Trial Name: NCT05868954 — N/A
Gestational Weight Gain Research Study Groups: American College of Obstetricians and Gynecologists (ACOG)-based Dietary Program, Mediterranean Diet (MedDiet) Program
Gestational Weight Gain Clinical Trial 2023: ACOG-based Dietary Program Highlights & Side Effects. Trial Name: NCT05868954 — N/A
ACOG-based Dietary Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05868954 — N/A
~4 spots leftby Dec 2024